Where can I buy Bausch Health shares?

Through a CIRO-regulated broker offering access to the TSX, holding the share in Canadian dollars in a registered account such as a TFSA or RRSP, or in a non-registered account. The stock also trades on the NYSE in US dollars. Some international brokers offer the share as a CFD, but they are not registered with CIRO and serve Canadian clients cross-border.

Is Bausch Health listed on the TSX?

Yes. Bausch Health trades under the symbol BHC on the Toronto Stock Exchange, quoted in Canadian dollars (CAD), and also lists on the NYSE in US dollars.

How are gains on Canadian shares taxed?

In a non-registered account, capital gains are taxed in Canada under the standard 50% inclusion rate as per Canadian tax law (CRA): half of a realised gain is added to your taxable income. Gains inside a TFSA are generally tax-free and inside an RRSP are tax-deferred. This is not tax advice.

Does HelloBrokers publish a price target for Bausch Health?

No. We do not publish price targets and we refuse to invent figures or a fake consensus. Where a credible, dated analyst view exists we cite the named source; otherwise we say there is none.

Share · TSX

Should you buy Bausch Health shares?

A diversified pharmaceutical company and turnaround story carrying a heavy debt load and legal overhangs. Here is our rating, the honest trade-offs, and how to buy the share from Canada.

Roch de Montesquieu Updated July 27, 2026

6.0/10 HelloBrokers rating

Key points

A diversified pharmaceutical company with a global product portfolio.
A turnaround story focused on reducing debt and simplifying the business.
Listed on the TSX (and also on the NYSE); here we treat the TSX line.
Trade-offs: a heavy debt load and ongoing litigation and legal overhangs.

Bausch Health is a diversified pharmaceutical company with a portfolio spanning several therapeutic areas, working through a multi-year turnaround focused on debt reduction. It is listed on the Toronto Stock Exchange (TSX) and also on the NYSE; here we treat the TSX line, quoted in Canadian dollars. Our rating follows the HelloBrokers methodology: we weigh the fundamentals, the competitive position and the risks, and we do not publish made-up price targets or a fabricated analyst consensus. Below we set out what we like, the risks to keep in mind, and the practical ways to buy the share from Canada through a CIRO-regulated broker.

Strengths

A diversified pharmaceutical portfolio across therapeutic areas
A defined turnaround plan focused on debt reduction
Established products generating ongoing revenue
Potential upside if deleveraging and simplification succeed

Watch-outs

A heavy debt load that dominates the investment case
Ongoing litigation and legal overhangs
Turnaround execution risk over several years
Priced in CAD on the TSX, with a parallel NYSE listing

Country 🇨🇦 Canada Listed on the TSX (and NYSE); TSX line quoted in CAD.

Market / ticker TSX: BHC Standard TSX symbol; also trades on the NYSE.

Situation Turnaround Multi-year deleveraging as publicly reported.

Sector Healthcare · Pharmaceuticals Business classification.

6.0/10

High-risk pharma turnaround

A diversified pharmaceutical company working through a debt-heavy turnaround. Our view weighs the potential upside against significant leverage and legal risk, without hype and without invented targets.

Best for Risk-tolerant investors who understand turnaround and high-debt situations. Not for Investors who want low volatility, low debt or a clean legal picture.

This is analysis, not investment advice. The bull case: a diversified pharmaceutical portfolio across therapeutic areas, a defined turnaround plan focused on debt reduction, and potential upside if deleveraging and simplification succeed.

The bear case: a heavy debt load dominates the investment case, and the company faces ongoing litigation and legal overhangs plus multi-year execution risk. As with any single stock, returns are also affected by the wider market and by news flow around its balance sheet.

Overall we see Bausch Health as a high-risk pharma turnaround. It can suit a risk-tolerant investor who understands the situation. As always, we do not publish made-up price targets.

There are two main routes. For most Canadian investors the cash share through a regulated broker is the more suitable one. A broker comparison is below.

Cash / spot

Buy the cash share through a broker

Open an account with a CIRO-regulated broker and hold the TSX-listed share directly in Canadian dollars, with full shareholder rights. You can hold it in a registered account such as a TFSA or RRSP, or in a non-registered account. In a non-registered account, capital gains are taxed in Canada under the standard 50% inclusion rate as per Canadian tax law (CRA), meaning half of a realised gain is added to your taxable income. This is the most direct way to invest for the long term. This is not tax advice.

CFD (leveraged)

Trade it as a CFD (leverage)

Some international brokers offer share CFDs. Leverage amplifies both gains and losses, the cost is the spread plus overnight financing, and you do not own the share. These international brokers are not registered with CIRO and serve Canadian clients cross-border. CFDs suit short-term traders who understand the risk; most retail CFD accounts lose money.

For most investors, buying the cash share through a CIRO-regulated broker and holding for the long term is the most suitable approach. Compare brokers below.

To buy Bausch Health, favour a CIRO-regulated broker with low fees and good coverage of Canadian shares. Compare them side by side below.

Compare brokers

: Through a CIRO-regulated broker offering access to the TSX, holding the share in Canadian dollars in a registered account such as a TFSA or RRSP, or in a non-registered account. The stock also trades on the NYSE in US dollars. Some international brokers offer the share as a CFD, but they are not registered with CIRO and serve Canadian clients cross-border.
: Yes. Bausch Health trades under the symbol BHC on the Toronto Stock Exchange, quoted in Canadian dollars (CAD), and also lists on the NYSE in US dollars.
: In a non-registered account, capital gains are taxed in Canada under the standard 50% inclusion rate as per Canadian tax law (CRA): half of a realised gain is added to your taxable income. Gains inside a TFSA are generally tax-free and inside an RRSP are tax-deferred. This is not tax advice.
: No. We do not publish price targets and we refuse to invent figures or a fake consensus. Where a credible, dated analyst view exists we cite the named source; otherwise we say there is none.

Why trust the HelloBrokers view on this share

We are an independent editorial team. Bausch Health does not pay us, and we do not publish invented price targets or a fake analyst consensus. The rating follows our methodology; affiliate links to brokers fund our work but never change the conclusion.

This content is for information only and is not investment advice, a recommendation or an offer. Past performance does not guarantee future results. Investing in shares carries a risk of capital loss; CFDs amplify that risk. Do your own research and consult a qualified professional where needed.

Should you buy Bausch Health shares?

Bausch Health overview

Bausch Health at a glance